Performance History
| Key Stats | |
|---|---|
| Open | $539.10 |
| Prev. Close | $538.58 |
| EPS | 26.49 |
| Dividend | $6.22 |
| Next Earnings Date | Sep 30, 2024 |
| Dividend Yield % | 1.22% |
| Market Cap | $124.61B |
| PE Ratio | 20.35 |
| LOW | HIGH | |
|---|---|---|
| Day Range | 538.21 | 543.13 |
| 52 Week Range | 412.00 | 543.13 |
| Ratios | |
|---|---|
| P/B Ratio | 2.94 |
| Revenue | - |
| Operating M. % | 7.53% |
| Earnings | $5.99B |
| Earnings Growth % | -0.47% |
| EBITDA Margin % | 6.51% |
| ROEÂ % | 15.96% |
| EPS | 26.49 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
All Score 72 / 100 is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.
| ELV | MARKET | |
|---|---|---|
| Value | 38 | 38 |
| Quality | 70 | 40 |
| Ownership | 40 | 17 |
| Growth | 63 | 46 |
| Dividends | 39 | 37 |
Elevance Health's Price growth average in the last 3 years of 10.59% is great compared to market average of 7.76%. This indicates ELV could be a good value stock.
Financial Forecast
AI Price Prediction
Analyst Ratings
Correlated Companies
About Elevance Health (ELV)
- Sector
- Healthcare
- Industry
- Healthcare Plans
- CEO
- Ms. Gail Koziara Boudreaux
- Headquarters
- Indianapolis
- Employees
- 102300
- Exchange
- NYSE
Keep an eye on Elevance Health
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
What is Elevance Health's (ELV) price per share?
The current price per share for Elevance Health (ELV) is $539.18. The stock has seen a price change of $0.6 recently, indicating a 0.11% change. This reflects the stock's recent market performance and investor sentiment.
What is the 52-week high and low for Elevance Health (ELV)?
For Elevance Health (ELV), the 52-week high is $543.13, which is 0.73% from the current price. The 52-week low is $412, the current price is 30.87% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
Is Elevance Health (ELV) a growth stock?
Elevance Health (ELV) has shown an average price growth of 0.41% over the past three years. It has received a score of 76 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Elevance Health as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
What is Elevance Health (ELV) stock price performance year to date (YTD)?
As of the latest data, Elevance Health (ELV) has a year-to-date price change of 12.6%. Over the past month, the stock has experienced a price change of 7.41%. Over the last three months, the change has been 6.72%. Over the past six months, the figure is 16.86%.
Is Elevance Health (ELV) a profitable company?
Elevance Health (ELV) has a net income of $5.99B, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 89.91% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 7.53% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 9.42%, providing insight into the company's sales performance and growth. Operating income is noted at -$4M. Furthermore, the EBITDA is $11.15B.
What is the market capitalization of Elevance Health (ELV)?
Elevance Health (ELV) has a market capitalization of $124.62B. The average daily trading volume is 828.31K, indicating the stock's liquidity and investor engagement.
News
Xiaomi and Samsung Smartphones Identified Among Top Radiation Emitters in 2024
Traders Pile Up Short Positions as Grayscale Abandons Ethereum Futures ETF Plan
Global Smartphone Shipments Jump by 20 Million Units Year-over-Year in Q1 2024
Pixel 8a Unveiled: Google’s AI Revolution Goes Mainstream
Visa’s Quarterly Revenue Jumped by $800 Million YoY and Hit an All-Time High of $8.75 Billion
Samsung Overtakes Apple in Q1 2024 Mobile Phone Shipments with 20.8% Market Share
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.